Andrew Albert Kucharchuk - May 30, 2025 Form 4 Insider Report for CERO THERAPEUTICS HOLDINGS, INC. (CERO)

Role
Chief Financial Officer
Signature
/s/ Chris Ehrlich, Attorney-in-Fact
Stock symbol
CERO
Transactions as of
May 30, 2025
Transactions value $
$0
Form type
4
Date filed
6/2/2025, 04:57 PM
Previous filing
Oct 2, 2024
Next filing
Aug 5, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KUCHARCHUK ANDREW ALBERT Chief Financial Officer CERO THERAPEUTICS HOLDINGS, INC., 201 HASKINS WAY, SUITE 230, SOUTH SAN FRANCISCO /s/ Chris Ehrlich, Attorney-in-Fact 2025-06-02 0001654127

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CERO Stock Option (Right to Buy) Award $0 +153K $0.00 153K May 30, 2025 Common Stock 153K $0.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest in equal monthly installments through June 4, 2027.